Noveris Health Sciences Inc. (MYCOF)
OTC
Closed
Sep 24, 2026
Day's Range
0.730052 wk Range
0.0960Overview - MYCOF - Noveris Health Sciences Inc.
Key Statistics
Valuation
Enterprise Value
30.63M
P/E (Trailing)
‪0.43‬
P/E (Forward)
‪0.32‬
PEG Ratio
‪-0.0043‬
Price / Book
‪-19.15‬
EV / EBITDA
‪-31.87‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-115.46%‬
Return on Equity
‪-23.42%‬
Ownership
Shares Outstanding
58.54M
Float
58.52M
Held by Insiders
‪0.05%‬
Held by Institutions
‪6.57%‬
Price stats
Beta
‪-5.65‬
50-Day Avg
‪1.01‬
200-Day Avg
‪0.7757‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MYCOF - Noveris Health Sciences Inc.
Peers - MYCOF - Noveris Health Sciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- MYCOFOTCNoveris Health Sciences Inc.42.74MMarket Cap+81.51%52-week change0.43P/E (Trailing)‪0.00%‬Profit Margin
- MKGAFOTCMerck KGaA67.92BMarket Cap+9.27%52-week change25.32P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR67.10BMarket Cap+8.97%52-week change24.90P/E (Trailing)‪11.21%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR45.20BMarket Cap+7.87%52-week change53.10P/E (Trailing)‪14.57%‬Profit Margin
- GDERFOTCGalderma Group AG44.15BMarket Cap+11.81%52-week change51.88P/E (Trailing)‪14.57%‬Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.43.14BMarket Cap-30.46%52-week change37.14P/E (Trailing)‪86.20%‬Profit Margin
- HLNCFOTCHaleon plc38.69BMarket Cap+1.79%52-week change18.58P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - MYCOF - Noveris Health Sciences Inc.
About
Noveris Health Sciences Inc. is a publicly traded, pre-revenue biopharmaceutical company engaged in the research, development, and commercialization of psychedelic-inspired medications to treat mental health and neurological conditions. The company focuses on developing second-generation compounds derived from…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
